Copertina

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms

Mostra altre versioni (1)

Mucinous ovarian tumors represent a distinct histotype of epithelial ovarian cancer. The rarest (2-4 % of ovarian carcinomas) of the five major histotypes, their genomic landscape remains poorly described. We undertook hotspot sequencing of 50 genes commonly mutated in human cancer across 69 mucinou...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Mackenzie, Robertson (Autore) , Kommoss, Stefan (Autore) , Winterhoff, Boris Jan Nils (Autore) , Kipp, Benjamin R. (Autore) , Garcia, Joaquin J. (Autore) , Voss, Jesse (Autore) , Halling, Kevin (Autore) , Karnezis, Anthony (Autore) , Senz, Janine (Autore) , Yang, Winnie (Autore) , Prigge, Elena-Sophie (Autore) , Reuschenbach, Miriam (Autore) , Knebel Doeberitz, Magnus von (Autore) , Gilks, Blake C. (Autore) , Huntsman, David G. (Autore) , Bakkum-Gamez, Jamie (Autore) , McAlpine, Jessica N. (Autore) , Anglesio, Michael S. (Autore)
Natura: Article (Journal)
Lingua:inglese
Pubblicazione: 19 May 2015
In: BMC cancer
Year: 2015, Volume: 15
ISSN:1471-2407
DOI:10.1186/s12885-015-1421-8
Accesso online:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12885-015-1421-8
Testo
Note sull'autore:Robertson Mackenzie, Stefan Kommoss, Boris J. Winterhoff, Benjamin R. Kipp, Joaquin J. Garcia, Jesse Voss, Kevin Halling, Anthony Karnezis, Janine Senz, Winnie Yang, Elena-Sophie Prigge, Miriam Reuschenbach, Magnus Von Knebel Doeberitz, Blake C. Gilks, David G. Huntsman, Jamie Bakkum-Gamez, Jessica N. McAlpine and Michael S. Anglesio
Descrizione
Riassunto:Mucinous ovarian tumors represent a distinct histotype of epithelial ovarian cancer. The rarest (2-4 % of ovarian carcinomas) of the five major histotypes, their genomic landscape remains poorly described. We undertook hotspot sequencing of 50 genes commonly mutated in human cancer across 69 mucinous ovarian tumors. Our goals were to establish the overall frequency of cancer-hotspot mutations across a large cohort, especially those tumors previously thought to be “RAS-pathway alteration negative”, using highly-sensitive next-generation sequencing as well as further explore a small number of cases with apparent heterogeneity in RAS-pathway activating alterations.
Descrizione del documento:Gesehen am 04.06.2020
Descrizione fisica:Online Resource
ISSN:1471-2407
DOI:10.1186/s12885-015-1421-8

Documenti analoghi